ARTICLE | Clinical News
Roclatan: Phase III started
September 28, 2015 7:00 AM UTC
Aerie began the double-blind, U.S. Phase III Mercury 1 trial to compare once-daily 0.02% Roclatan eye drops for 1 year vs. each of its components -- once-daily Rhopressa and latanoprost -- in about 69...